MX2017008495A - Nuevos derivados de bencimidazol como agentes antihistaminicos. - Google Patents

Nuevos derivados de bencimidazol como agentes antihistaminicos.

Info

Publication number
MX2017008495A
MX2017008495A MX2017008495A MX2017008495A MX2017008495A MX 2017008495 A MX2017008495 A MX 2017008495A MX 2017008495 A MX2017008495 A MX 2017008495A MX 2017008495 A MX2017008495 A MX 2017008495A MX 2017008495 A MX2017008495 A MX 2017008495A
Authority
MX
Mexico
Prior art keywords
benzimidazole derivatives
antihistamine agents
new benzimidazole
compounds
new
Prior art date
Application number
MX2017008495A
Other languages
English (en)
Other versions
MX371102B (es
Inventor
Rodes Solanes Rosa
Olivera Tizne Roberto
Hernández Herrero Gonzalo
RUBIO ROYO Víctor
Ledo Gómez Francisco
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of MX2017008495A publication Critical patent/MX2017008495A/es
Publication of MX371102B publication Critical patent/MX371102B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a compuestos de fórmula (I): (ver Fórmula) o una sal o un solvato farmacéuticamente aceptable de los mismos, a un método de síntesis de dichos compuestos, a composiciones farmacéuticas que comprenden los mismos y a su uso en el tratamiento y/o la prevención de estados mediados por el receptor histamínico H1, tales como enfermedades o trastornos alérgicos.
MX2017008495A 2014-12-29 2015-12-28 Nuevos derivados de bencimidazol como agentes antihistaminicos. MX371102B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382576.8A EP3040334A1 (en) 2014-12-29 2014-12-29 New benzimidazole derivatives as antihistamine agents
PCT/EP2015/081292 WO2016107848A1 (en) 2014-12-29 2015-12-28 New benzimidazole derivatives as antihistamine agents

Publications (2)

Publication Number Publication Date
MX2017008495A true MX2017008495A (es) 2017-09-19
MX371102B MX371102B (es) 2020-01-16

Family

ID=52302107

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008495A MX371102B (es) 2014-12-29 2015-12-28 Nuevos derivados de bencimidazol como agentes antihistaminicos.

Country Status (17)

Country Link
US (1) US10106522B2 (es)
EP (2) EP3040334A1 (es)
JP (1) JP6585718B2 (es)
KR (1) KR20170097669A (es)
CN (1) CN107108575B (es)
AU (1) AU2015373457B2 (es)
BR (1) BR112017013998A2 (es)
CA (1) CA2970854A1 (es)
CL (1) CL2017001720A1 (es)
CO (1) CO2017005806A2 (es)
EA (1) EA033827B1 (es)
ES (1) ES2706475T3 (es)
MX (1) MX371102B (es)
PE (1) PE20171089A1 (es)
PT (1) PT3240783T (es)
WO (1) WO2016107848A1 (es)
ZA (1) ZA201704462B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
US11642309B2 (en) * 2017-10-16 2023-05-09 Faes Farma, S.A. Aqueous compositions comprising bilastine and mometasone
LT3740191T (lt) 2018-01-18 2021-08-10 Faes Farma, S.A. Oftalmologinės kompozicijos, apimančios bilastiną, beta-ciklodekstriną ir bent vieną gelinimo agentą
DE102019211434B3 (de) 2019-07-31 2020-11-05 Premium Aerotec Gmbh Spantkomponente und verfahren zur herstellung einer spantkomponente, spant und rumpfstruktur für ein luftfahrzeug
WO2023156559A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238863A (en) * 1990-07-19 1993-03-26 Janssen Pharmaceutica Nv Substituted thiazolyl and pyridinyl derivatives
ES2048109B1 (es) 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2124167B1 (es) 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
WO2002034719A1 (fr) * 2000-04-21 2002-05-02 Sankyo Company, Limited Composes heterocycliques azotes satures
JP2001011050A (ja) * 1999-04-30 2001-01-16 Sankyo Co Ltd 含窒素飽和複素環化合物
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2002212683A1 (en) * 2000-10-30 2002-05-15 Sankyo Company, Limited Preventive or therapeutic medicines for hepatitis and/or hepatopathy
JP2002322059A (ja) * 2001-04-25 2002-11-08 Sankyo Co Ltd 炎症性腸疾患の予防又は治療剤
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents

Also Published As

Publication number Publication date
AU2015373457B2 (en) 2019-09-19
EP3240783A1 (en) 2017-11-08
CL2017001720A1 (es) 2018-03-16
CN107108575B (zh) 2019-07-26
ES2706475T3 (es) 2019-03-29
EP3040334A1 (en) 2016-07-06
CA2970854A1 (en) 2016-07-07
US20180016251A1 (en) 2018-01-18
CO2017005806A2 (es) 2017-09-20
ZA201704462B (en) 2019-09-25
JP6585718B2 (ja) 2019-10-02
JP2018502075A (ja) 2018-01-25
MX371102B (es) 2020-01-16
KR20170097669A (ko) 2017-08-28
WO2016107848A1 (en) 2016-07-07
EP3240783B1 (en) 2018-11-21
PE20171089A1 (es) 2017-08-03
PT3240783T (pt) 2019-01-28
US10106522B2 (en) 2018-10-23
EA033827B1 (ru) 2019-11-29
AU2015373457A1 (en) 2017-07-27
EA201791480A1 (ru) 2017-11-30
CN107108575A (zh) 2017-08-29
BR112017013998A2 (pt) 2018-03-06

Similar Documents

Publication Publication Date Title
MX2016011632A (es) Derivados de azaspiro como antagonistas de trpm8.
MX2020010484A (es) Derivados de heterociclilos sustituidos como inhibidores de cdk.
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
PH12016501972B1 (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
PH12016501457A1 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
MX2018009257A (es) Derivados de benzimidazol como moduladores de ror-gamma.
MY182454A (en) Dihydropyrrolopyridine inhibitors of ror-gamma
EA033544B1 (ru) Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret)
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
MX2017002816A (es) Derivados de pirazolopiridina y su uso en terapia.
CO2017005806A2 (es) Nuevos derivados de bencimidazol como agentes antihistamínicos
MX2017001103A (es) Derivados de indolizina que son aplicables a enfermedades neurodegenerativas.
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
SA519410097B1 (ar) P2x7 مشتقات رباعي هيدروكوينولين كمعارضات مستقبل
PH12021550143A1 (en) Pyridopyrimidines as histamine h4-receptor inhibitors
MX2017002544A (es) Derivados de isoquinolinona utiles en el tratamiento contra el cancer.
PH12017501736A1 (en) Indole derivatives
PH12017501134A1 (en) Fumagillol derivatives
MX2017013103A (es) Metodos para el tratamiento de trastornos cardiovasculares.
MX2017008497A (es) Nuevos compuestos heterocíclicos y su uso tanto en medicina como en cosmética.

Legal Events

Date Code Title Description
FG Grant or registration